(Q45117334)

9 December 2017

title

Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells (English)

1 reference

9 December 2017

1 reference

7

Curiel DT

1 reference

9 December 2017

Rivera AA

1

1 reference

9 December 2017

Davydova J

2

1 reference

9 December 2017

Schierer S

3

1 reference

9 December 2017

Wang M

4

1 reference

9 December 2017

Krasnykh V

5

1 reference

9 December 2017

Yamamoto M

6

1 reference

9 December 2017

Nettelbeck DM

8

1 reference

9 December 2017

publication date

1 December 2004

1 reference

9 December 2017

1 reference

9 December 2017

volume

11

1 reference

9 December 2017

issue

23

1 reference

9 December 2017

page(s)

1694-1702

1 reference

Replicative adenoviruses for cancer therapy

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Development and application of adenoviral vectors for gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Retargeting of adenoviral infection to melanoma: Combining genetic ablation of native tropism with a recombinant bispecific single‐chain diabody (scDb) adapter that binds to fiber knob and HMWMAA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Intravascular adenoviral agents in cancer patients: lessons from clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Targeted adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Genetic targeting of adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Enhanced Adenovirus Infection of Melanoma Cells by Fiber-Modification: Incorporation of RGD Peptide or Ad5/3 Chimerism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

A dual specificity promoter system combining cell cycle-regulated and tissue-specific transcriptional control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Genetic manipulations of adenovirus type 5 fiber resulting in liver tropism attenuation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

CD46 is a cellular receptor for group B adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Dual targeting of adenoviral vectors at the levels of transduction and transcription enhances the specificity of gene expression in cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Melanoma genetics: an update with focus on the CDKN2A(p16)/ARF tumor suppressors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Dependence of adenovirus infectivity on length of the fiber shaft domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Adenovirus type 11 uses CD46 as a cellular receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302346

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302346

1 reference

Dimensions Publication ID

9 December 2017

1000819417

0 references

1 reference